Abstract
To investigate endothelial cell alterations in BMT recipients developing acute graft-versus-host disease (aGVHD) we determined levels of the endothelial cell markers von Willebrand factor (VWF) and thrombomodulin (TM) in 57 patients undergoing BMT. Before conditioning VWF and TM levels did not differ significantly between transplant recipients who later developed no or mild (grade I) aGVHD (group A, allogeneic n = 22, autologous n = 7; VWF 136.0 ± 44.1%; TM 29.5 ± 18.0 ng/ml), and those with moderate or severe (grade II or III) aGVHD (group B, n = 28; VWF 142.2 ± 37.6%; TM 35.2 ± 20.1 ng/ml). A first significant rise of both VWF and TM levels was noted after conditioning (day 0) both in group A (VWF 197.0 ± 113.3%; P < 0.001; tm 39.3 ± 23.3 ng/ml; P < 0.01) as well as in group b (vwf 201.7 ± 53.3%; P < 0.0001; tm 43.5 ± 23.5 ng/ml; P < 0.05). subgroup analysis of autografted patients revealed no significant increase after conditioning in these patients. at the time of engraftment and onset of agvhd (day 21), when vwf and tm levels within the groups were significantly elevated as compared with baseline (day −8) levels, group b patients (62.7 ± 38.5 ng/ml) had significantly higher (P < 0.01) tm levels than patients of group a (37.4 ± 19.6 ng/ml). this significant elevation also persisted at the end of the investigational period (day 28; group b: 56.0 ± 37.6 ng/ml; group a: 38.2 ± 23.7 ng/ml; P < 0.01). an elevation of endothelial cell markers is found in the course of bmt, particularly after conditioning and at the time of engraftment. this increase is pronounced in patients with agvhd suggesting not only epithelial cell but also endothelial cell injury during agvhd.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Salat, C., Holler, E., Kolb, HJ. et al. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease. Bone Marrow Transplant 19, 909–914 (1997). https://doi.org/10.1038/sj.bmt.1700767
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700767
Keywords
This article is cited by
-
Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation
Bone Marrow Transplantation (2021)
-
High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group
Blood Cancer Journal (2021)
-
Endothelial damage is aggravated in acute GvHD and could predict its development
Bone Marrow Transplantation (2017)
-
Bone marrow sinusoidal endothelium: damage and potential regeneration following cancer radiotherapy or chemotherapy
Angiogenesis (2017)
-
Angiogenic factors are associated with development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Journal of Huazhong University of Science and Technology [Medical Sciences] (2015)